Paulsen's study investigated whether
the addition of molecular imaging (NIRST) at the time of MRI would improve the diagnostic accuracy of breast MRI alone by contributing functional information about regions of suspicion in the breast identified by the MRI and helping to categorize the regions as malignant or benign.
In
addition, they integrate their research objectives with those
of the Biomarker Sciences Program committees to incorporate predictive / prognostic
molecular and
imaging biomarkers into therapeutic trials, whenever possible.